Insulin Glargine vs Ipilimumab

## Insulin Glargine vs Ipilimumab: Overview

This comparison examines the pharmacological differences between **Insulin Glargine** and **Ipilimumab**.

## Mechanism of Action

**Insulin Glargine**: Long-acting insulin analogue that binds insulin receptors.

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

## Pharmacokinetics

**Half-life**: Insulin Glargine — 12-24 hours; Ipilimumab — 14.7 days.

## Chemical Properties

**Type**: Insulin Glargine — Protein; Ipilimumab — Antibody.